Vontobel Financial Products GmbH Stock

Certificat

DE000VD25XM9

Real-time Boerse Frankfurt Warrants 07:54:01 2024-06-27 am EDT
101.3 EUR +0.32% Intraday chart for Vontobel Financial Products GmbH
Current month-1.29%
1 month-1.35%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-27 101.3 +0.32%
24-06-26 101 -0.39%
24-06-25 101.4 -0.25%
24-06-24 101.6 -0.64%
24-06-21 102.3 +0.07%

Real-time Boerse Frankfurt Warrants

Last update June 27, 2024 at 07:54 am EDT

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
IssuerLogo Issuer Vontobel Vontobel
WKN VD25XM
ISINDE000VD25XM9
Date issued 2024-04-04
Strike 15 $
Maturity 2025-06-20 (358 Days)
Parity 0.01 : 1
Emission price 100
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 103.6
Lowest since issue 93.55
Spread 11.3
Spread %1.10%

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.25 USD
Average target price
18.74 USD
Spread / Average Target
+15.30%
Consensus